Date of publication: May 2, 2012

News & Views

First results of the CompAct Survey

The COMPACT SURVEY started in November 2011. At the occasion of the ASN congress in Philadelphia, USA, 38 healthcare professionals participated and the overall results so far have been analyzed:

  • The participating physicians are convinced that dialysis patients do not know about the consequences of hyperphosphatemia and that this is the foremost reason for noncompliance.
  • The physicians know about the high pill burden of their patients and do rank this as one of the major problems when it comes to therapy adherence.
  • In the eyes of the physicians the best way to raise the awareness of patients towards the lifelong consequences of hyperphosphatemia is the personal conversation with a healthcare professional.
  • Brochures and online channels are not deemed as effective.
  • Physicians do agree, that serum phosphorous is the most important parameter for achieving good results in hyperphosphatemia therapy and that treatment should be started at a phosphorous level of 4.5 to 5.5 mg/dl.



Leave a Reply


You are about to leave

Clicking the "Continue" link below will take you to an external website. Compact Renal is not responsible for the contents of any external website. Compact Renal is providing these links to you as a convenience, and the inclusion of any links does not imply endorsement of the linked site by Compact Renal.

Do you wish to continue?

Continue Cancel